Table 3 Data on the 335 patients who completed the follow-up
From: Prevalence of airflow obstruction in patients with stable systolic heart failure
Baseline | Follow-up | P | |
|---|---|---|---|
NYHA III-IV n(%) | 74 (22%) | 33 (10%) | <0.01 |
Weight, kg (SD) | 82 (19) | 82 (20) | 0.39 |
Systolic blood pressure, mmHg (SD) | 129 (20) | 124 (21) | <0.01 |
Diastolic blood pressure, mmHg (SD) | 77 (14) | 74 (11) | 0.01 |
Heart rate, /minute (SD) | 74 (15) | 67 (13) | <0.01 |
ACE-inhibitor, % of recommended dose (SD) | 46 (35) | 68 (42) | <0.01 |
Beta-blocker, % of recommended dose (SD) | 32 (30) | 63 (38) | <0.01 |
Dose of furosemide, mg (SD) | 61 (108) | 56 (107) | 0.03 |
Treated with spironolactone, n(%) | 58 (18%) | 73 (22%) | 0.01 |
FEV1, % of expected (SD) | 77 (19) | 76 (22) | 0.11 |
FVC, % of expected (SD) | 85 (18) | 84 (21) | 0.27 |
FEV1/FVC, (SD) | 0.72 (0.10) | 0.71 (0.11) | 0.22 |